MXPA05012838A - Procedimiento mejorado. - Google Patents

Procedimiento mejorado.

Info

Publication number
MXPA05012838A
MXPA05012838A MXPA05012838A MXPA05012838A MXPA05012838A MX PA05012838 A MXPA05012838 A MX PA05012838A MX PA05012838 A MXPA05012838 A MX PA05012838A MX PA05012838 A MXPA05012838 A MX PA05012838A MX PA05012838 A MXPA05012838 A MX PA05012838A
Authority
MX
Mexico
Prior art keywords
preparation
hemisulphate
eleptritan
anhydrous
polymorph
Prior art date
Application number
MXPA05012838A
Other languages
English (en)
Inventor
Julie Ann Macrae
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MXPA05012838A publication Critical patent/MXPA05012838A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)

Abstract

La presente invencion proporciona un procedimiento mejorado para la preparacion de un polimorfo de hemisulfato de eletriptan.
MXPA05012838A 2003-05-30 2004-05-18 Procedimiento mejorado. MXPA05012838A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0312478.1A GB0312478D0 (en) 2003-05-30 2003-05-30 Improved process
PCT/IB2004/001694 WO2004106327A1 (en) 2003-05-30 2004-05-18 Process for the preparation of anhydrous eleptritan hemisulphate

Publications (1)

Publication Number Publication Date
MXPA05012838A true MXPA05012838A (es) 2006-02-13

Family

ID=9959072

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05012838A MXPA05012838A (es) 2003-05-30 2004-05-18 Procedimiento mejorado.

Country Status (10)

Country Link
EP (1) EP1633739A1 (es)
JP (1) JP2006528968A (es)
AR (1) AR044463A1 (es)
BR (1) BRPI0410841A (es)
CA (1) CA2527127A1 (es)
CL (1) CL2004001132A1 (es)
GB (1) GB0312478D0 (es)
MX (1) MXPA05012838A (es)
TW (1) TWI290923B (es)
WO (1) WO2004106327A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651637B2 (en) * 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
WO1999001135A1 (en) * 1997-07-03 1999-01-14 Pfizer Limited Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt

Also Published As

Publication number Publication date
TWI290923B (en) 2007-12-11
GB0312478D0 (en) 2003-07-09
TW200427683A (en) 2004-12-16
JP2006528968A (ja) 2006-12-28
CL2004001132A1 (es) 2005-03-18
EP1633739A1 (en) 2006-03-15
AR044463A1 (es) 2005-09-14
BRPI0410841A (pt) 2006-06-27
CA2527127A1 (en) 2004-12-09
WO2004106327A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
GB0124627D0 (en) Novel compounds
HK1068626A1 (en) Chemical compounds
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
IL163777A0 (en) Kinase inhibitors
SI1509517T1 (sl) Nova sinteza irbesartana
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
SG144736A1 (en) Synthesis of temozolomide and analogs
PL1877370T3 (pl) Sposób wytwarzania pochodnych hydrazonu
SG143062A1 (en) Synthesis of temozolomide and analogs
GB0327323D0 (en) Novel pharmaceuticals
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY138550A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
TW200630369A (en) Process for preparing purine compounds
NO20053208D0 (no) Metode for reduktiv dehalogenering.
GB0215392D0 (en) Chemical compounds
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
MY139348A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MXPA05012838A (es) Procedimiento mejorado.
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MXPA05004262A (es) Proceso para elaborar compuestos de pirazol.